Support the news

Glaxo To Pay $40M For Faulty Medications

This article is more than 8 years old.
The British drug giant agrees to a settlement for selling substandard antidepressants, among other medicines
The British drug giant agrees to a settlement for selling substandard antidepressants, among other medicines

British drugmaker GlaxoSmithKline PLC will pay $40.75 million to 37 states and the District of Columbia for selling substandard antidepressants and other medicines produced at its former Puerto Rico factory.

The states and the District of Columbia filed complaints against the company under their consumer protection laws following a $750 million settlement with the federal government last October.

Both settlements involve production of adulterated, or substandard, products made from 2001 through 2005 at a factory in Cidra, Puerto Rico. Those included antidepressant Paxil CR, anti-infection ointment Bactroban, sterile anti-nausea medication Kytril and combination Type 2 diabetes pill Avandamet.

GSK admits no wrongdoing.

This program aired on June 23, 2011. The audio for this program is not available.

Rachel Zimmerman Twitter Health Reporter
Rachel Zimmerman previously reported on health and the intersection of health and business for Bostonomix.

More…

+Join the discussion
TwitterfacebookEmail

Support the news